Insider · CIK 0001588273

Poplar Point Capital Management LLC

CIK 0001588273 Name as filed on the most recent filing

Filed as Poplar Point Capital Management LLC (15)

50 transaction lines · from 15 filings · filed 2014-11-13 to 2025-04-15 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2025-04-08 P, Open-market purchase NovaBay Pharmaceuticals, Inc.NBY 140, acquired Open Form 4 filing 0001398344-25-007148
2025-04-04 P, Open-market purchase NovaBay Pharmaceuticals, Inc.NBY 2,367, acquired Open Form 4 filing 0001398344-25-007148
2025-04-03 P, Open-market purchase NovaBay Pharmaceuticals, Inc.NBY 12,929, acquired Open Form 4 filing 0001398344-25-007148
2025-04-02 P, Open-market purchase NovaBay Pharmaceuticals, Inc.NBY 532, acquired Open Form 4 filing 0001398344-25-007148
2025-04-01 P, Open-market purchase NovaBay Pharmaceuticals, Inc.NBY 11,650, acquired Open Form 4 filing 0001398344-25-007146
2025-03-31 P, Open-market purchase NovaBay Pharmaceuticals, Inc.NBY 12,776, acquired Open Form 4 filing 0001398344-25-007146
2025-03-28 P, Open-market purchase NovaBay Pharmaceuticals, Inc.NBY 30,253, acquired Open Form 4 filing 0001398344-25-007146
2025-03-27 P, Open-market purchase NovaBay Pharmaceuticals, Inc.NBY 2 lines 11,745, acquired Open Form 4 filing 0001398344-25-007146
2025-03-26 P, Open-market purchase NovaBay Pharmaceuticals, Inc.NBY 8,095, acquired Open Form 4 filing 0001398344-25-007146
2025-03-25 P, Open-market purchase NovaBay Pharmaceuticals, Inc.NBY 13,807, acquired Open Form 4 filing 0001398344-25-007144
2025-03-24 P, Open-market purchase NovaBay Pharmaceuticals, Inc.NBY 61, acquired Open Form 4 filing 0001398344-25-007144
2025-03-21 P, Open-market purchase NovaBay Pharmaceuticals, Inc.NBY 3,855, acquired Open Form 4 filing 0001398344-25-007144
2025-03-20 P, Open-market purchase NovaBay Pharmaceuticals, Inc.NBY 3,271, acquired Open Form 4 filing 0001398344-25-007144
2025-03-19 P, Open-market purchase NovaBay Pharmaceuticals, Inc.NBY 904, acquired Open Form 4 filing 0001398344-25-007144
2025-03-18 P, Open-market purchase NovaBay Pharmaceuticals, Inc.NBY 6,300, acquired Open Form 4 filing 0001398344-25-007141
2025-03-18 P, Open-market purchase NovaBay Pharmaceuticals, Inc.NBY 8,820, acquired Open Form 4 filing 0001398344-25-007144
2025-03-14 P, Open-market purchase NovaBay Pharmaceuticals, Inc.NBY 16,072, acquired Open Form 4 filing 0001398344-25-007141
2025-03-13 P, Open-market purchase NovaBay Pharmaceuticals, Inc.NBY 22, acquired Open Form 4 filing 0001398344-25-007141
2025-03-12 P, Open-market purchase NovaBay Pharmaceuticals, Inc.NBY 7,370, acquired Open Form 4 filing 0001398344-25-007141
2025-03-11 P, Open-market purchase NovaBay Pharmaceuticals, Inc.NBY 1,246, acquired Open Form 4 filing 0001398344-25-007141
2025-03-10 P, Open-market purchase NovaBay Pharmaceuticals, Inc.NBY 8,494, acquired Open Form 4 filing 0001398344-25-007141
2025-03-07 P, Open-market purchase NovaBay Pharmaceuticals, Inc.NBY 56, acquired Open Form 4 filing 0001398344-25-007139
2025-03-04 P, Open-market purchase NovaBay Pharmaceuticals, Inc.NBY 2,314, acquired Open Form 4 filing 0001398344-25-007139
2025-02-28 P, Open-market purchase NovaBay Pharmaceuticals, Inc.NBY 7,891, acquired Open Form 4 filing 0001398344-25-007139
2025-02-27 P, Open-market purchase NovaBay Pharmaceuticals, Inc.NBY 235, acquired Open Form 4 filing 0001398344-25-007139
2025-02-26 P, Open-market purchase NovaBay Pharmaceuticals, Inc.NBY 3,844, acquired Open Form 4 filing 0001398344-25-007139
2025-02-25 P, Open-market purchase NovaBay Pharmaceuticals, Inc.NBY 15,518, acquired Open Form 4 filing 0001398344-25-007139
2025-02-24 P, Open-market purchase NovaBay Pharmaceuticals, Inc.NBY 279, acquired Open Form 4 filing 0001398344-25-007136
2025-02-20 P, Open-market purchase NovaBay Pharmaceuticals, Inc.NBY 1,157, acquired Open Form 4 filing 0001398344-25-007136
2025-02-19 P, Open-market purchase NovaBay Pharmaceuticals, Inc.NBY 33,349, acquired Open Form 4 filing 0001398344-25-007136
2025-02-18 P, Open-market purchase NovaBay Pharmaceuticals, Inc.NBY 2,127, acquired Open Form 4 filing 0001398344-25-007136
2025-02-04 P, Open-market purchase NovaBay Pharmaceuticals, Inc.NBY 16,966, acquired Open Form 4 filing 0001398344-25-007136
2025-02-03 P, Open-market purchase NovaBay Pharmaceuticals, Inc.NBY 1,649, acquired Open Form 4 filing 0001398344-25-007136
2025-01-31 P, Open-market purchase NovaBay Pharmaceuticals, Inc.NBY 45,825, acquired Open Form 4 filing 0001398344-25-007133
2025-01-27 P, Open-market purchase NovaBay Pharmaceuticals, Inc.NBY 21,875, acquired Open Form 4 filing 0001398344-25-007133
2021-08-30 S, Open-market sale Gyrodyne, LLCGYRO 80,600, disposed Open Form 4 filing 0001104659-21-111223
2021-08-27 S, Open-market sale Gyrodyne, LLCGYRO 391,200, disposed Open Form 4 filing 0001104659-21-111223
2016-05-17 P, Open-market purchase Swisher Hygiene Inc.SWSH 17,444, acquired Open Form 4 filing 0001144204-16-103183
2016-05-16 P, Open-market purchase Swisher Hygiene Inc.SWSH 36,566, acquired Open Form 4 filing 0001144204-16-103157
2016-05-16 S, Open-market sale Swisher Hygiene Inc.SWSH 36,566, acquired Open Form 4 filing 0001144204-16-103040
2016-05-13 P, Open-market purchase Swisher Hygiene Inc.SWSH 59,938, acquired Open Form 4 filing 0001144204-16-103157
2016-05-13 S, Open-market sale Swisher Hygiene Inc.SWSH 59,938, acquired Open Form 4 filing 0001144204-16-103040
2016-05-09 S, Open-market sale Swisher Hygiene Inc.SWSH 137,240, acquired Open Form 4 filing 0001144204-16-099862
2016-05-06 S, Open-market sale Swisher Hygiene Inc.SWSH 152,000, acquired Open Form 4 filing 0001144204-16-099862
2015-08-03 S, Open-market sale Sycamore Networks IncSCMR 1,728,529, disposed Open Form 4 filing 0001144204-15-046413
2015-07-01 P, Open-market purchase Emrise CorpEMRI 27,750, acquired Open Form 4 filing 0001144204-15-040886
2015-06-30 P, Open-market purchase Emrise CorpEMRI 154,953, acquired Open Form 4 filing 0001144204-15-040886
2014-10-10 P, Open-market purchase Sycamore Networks IncSCMR 286,112, acquired Open Form 4 filing 0001144204-14-067652
2014-07-16 P, Open-market purchase Sycamore Networks IncSCMR 49,920, acquired Open Form 4 filing 0001144204-14-067652

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. POPLAR POINT CAPITAL MANAGEMENT LLC, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001588273

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.